Chemotherapy for myeloid malignancy in children with Fanconi anemia

Pediatric Blood and Cancer

Volumn 48, Issue 7, 2007, Pages 668-672

  Mehta, Parinda A ^a,b,c   Ileri, Talia ^d   Harris, Richard E ^a,b,c   Williams, David A ^a,b,c   Mo, Jun ^b   Smolarek, Teresa ^b   Auerbach, Arleen D ^e   Kelly, Patrick ^a,b,c   Davies, Stella M ^a,b,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CCHMC   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d ANKARA UNIVERSITY   (Turkey)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Acute myeloid leukemia (AML); Chemotherapy; Fanconi anemia

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHILD; CONTROLLED STUDY; CYTOTOXICITY; FANCONI ANEMIA; FEMALE; HUMAN; MALE; MONOTHERAPY; PRIORITY JOURNAL; RASH; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FANCONI ANEMIA; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOID; MALE; MYELODYSPLASTIC SYNDROMES; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34248198839     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20843     Document Type: Article

References (27)

1. Kutler D, Singh B, Satagopan J, et al. A 20-year perspective on the international fanconi anemia registry (IFAR). Blood 2003;101:1249-1256.
2. Goldsby RE, Perkins SL, Virshup DM, et al. Lymphoblastic lymphoma and excessive toxicity from chemotherapy; an unusual presentation for fanconi anemia. J Pediatr Hematol Oncol 1999;21:240-243.
3. Ruud E, Wesenberg F. Microcephalus, medulloblastoma and excessive toxicity from chemotherapy; an unusual presentation of fanconi anemia. Acta Paediatrica 2001;90:580-583.
4. Verbeek W, Haase D, Schoch C, et al. Induction of hematological and cytogenetic remission in a patient with a myelodysplastic syndrome secondary to fanconi's anemia employing the S-HAM regimen. Ann Hematol 1997;74:275-277.
5. Ikeda H, Matsushita M, Waisfisz Q, et al. Genetic reversion in an acute myelogenous leukemia cell line from a fanconi anemia patient with biallelic mutations in BRCA2. Cancer Res 2003;63:2688-2694.
6. McCarthy AJ, Pitcher LA, Hann IM, et al. Flag (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children. Med Pediatr Oncol 1999;32:411-415.
7. Fleischhack G, Hasan C, Graf N, et al. IDA-FLAG (idarubicin, fludarabine, cytarabine, g-csf), an effective remission-induction therapy for poor prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: Experiences of a phase II trial. Br J Haematol 1998;102:647-655.
8. Keating MJ, O'Brien S, McLaughlin P, et al. Clinical experience with fludarabine in hemato-oncology. Hematol Cell Ther 1996;38:S83-91.
9. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993;21:731-733.
10. Hanenberg H, Batish SD, Pollok KE, et al. Phenotypic correction of primary fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp Hematol 2002;30:410-420.
11. Chandra S, Levran O, Jurickova I, et al. A rapid method for retrovirus-mediated identification of complementation groups in fanconi anemia patients. Mol Ther 2005;12:976-984.
12. Wagner JE, Tolar J, Levran O, et al. Germline mutations in BRCA2: Shared genetic susceptibility to breast cancer, early onset leukemia, and fanconi anemia. Blood 2004;103:3226-3229.
13. Slater SE, Maccallum PK, Birjandi F, et al. Acute myelogenous leukemia (AML) and diabetes insipidus (DI): Further association with monosomy 7. Hematol Oncol 1992;10:221-223.
14. Castagnola C, Morra E, Bernasconi P, et al. Acute myeloid leukemia and diabetes insipidus: Results in 5 patients. Acta Haematol 1995;93:1-4.
15. Lavabre-Bertrand T, Bourquard P, Chiesa J, et al. Diabetes insipidus revealing acute myelogenous leukaemia with a high platelet count, monosomy 7 and abnormalities of chromosome 3: A new entity? Eur J Haematol 2001;66:66-69.
16. Muller CI, Engelhardt M, Laubenberger J, et al. Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: Due to pituitary infiltration association with abnormalities of chromosomes 3 and 7. Eur J Haematol 2002;69:115-119.
17. Keung YK, Buss D, Powell BL, et al. Central diabetes insipidus and inv(3)(q21q26) and monosomy 7 in acute myeloid leukemia. Cancer Genet Cytogenet 2002;136:78-81.
18. Breccia M, Petti MC, Ottaviani E, et al. Alimena g. Diabetes insipidus as first manifestation of acute myeloid leukaemia with evi-1-positive, 3q21q26 syndrome and t cell-line antigen expression: What is the evi-1 gene role? Br J Haematol 2002;118:438-441.
19. Auerbach AD, Wolman SR. Susceptibility of fanconi's anemia fibroblasts to chromosome damage by carcinogens. Nature 1976;261:494-496.
20. Davies SM, Khan S, Wagner JE, et al. Unrelated donor bone marrow transplantation for fanconi anemia. Bone Marrow Transplant 1996;17:43-47.
21. Zwaan CM, Van Weel-Sipman MH, Fibbe WE, et al. Unrelated donor bone marrow transplant in fanconi anemia; the Leiden experience. Bone Marrow Transplant 1998;21:447-453.
22. Boulad F, Gillio A, Small TN, et al. Stem cell transplantation for the treatment of fanconi anemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 2000;111:1153-1157.
23. Guardiola P, Pasquini R, Dokal I, et al. Outcome of 69 allogeneic stem cell transplantations for fanconi anemia using HLA-matched unrelated donors; a study on behalf of the European group for blood and marrow transplantation. Blood 2000;95:422-429.
24. de Medeiros CR, Silva LM, Pasquini R. Unrelated cord blood transplantation in a fanconi anemia patient using fludarabine-based conditioning. Bone Marrow Transplant 2001;28:110-112.
25. de la Fuente J, Reiss S, McCloy M, et al. Non-TBI stem cell transplantation protocol for fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant 2003;32:653-656.
26. Butturini A, Gale RP, Verlander PC, et al. Hematologic abnormalities in fanconi anemia: An international fanconi anemia registry study. Blood 1994;84:1650-1655.
27. MacMillan ML, Weisdorf DJ, Slungaard A, et al. High probability of survival in standard risk patients with fanconi anemia after alternate donor hematopoietic transplantation. Blood 2002;100:857a.